5-bromo-2-(cyclobutylmethoxy)pyridine

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 5-bromo-2-(cyclobutylmethoxy)pyridine
• 英文别名: 5-Bromo-2-(cyclobutylmethoxy)pyridine
• 化学式: C₁₀H₁₂BrNO
• 分子量: 242.115
• InChiKey: LYCJYGNRJNLIOT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  22.1
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• [EN] BIARYLOXY DERIVATIVES AS TTX-S BLOCKERS<br/>[FR] DÉRIVÉS DE BIARYLOXY UTILISÉS EN TANT QUE BLOQUEURS DE TTX-S
  申请人：RAQUALIA PHARMA INC

  公开号：WO2019045035A1

  公开（公告）日：2019-03-07

  The present invention relates to biaryloxy derivatives which have blocking activities of voltage gated sodium channels as the TTX-S channels, and which are useful in the treatment or prevention of disorders and diseases in which voltage gated sodium channel is involved.　The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which voltage gated sodium channels are involved.

  本发明涉及具有阻断活性的双芳氧基衍生物，可作为TTX-S通道的阻断活性，并且可用于治疗或预防涉及电压门控钠通道的紊乱和疾病。该发明还涉及包含这些化合物的药物组合物以及在预防或治疗涉及电压门控钠通道的疾病中使用这些化合物和组合物。
• Biaryloxy derivatives as TTX-S blockers
  申请人：RaQualia Pharma Inc.

  公开号：US11020381B2

  公开（公告）日：2021-06-01

  The present invention relates to biaryloxy derivatives which have blocking activities of voltage gated sodium channels as the TTX-S channels, and which are useful in the treatment or prevention of disorders and diseases in which voltage gated sodium channel is involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which voltage gated sodium channels are involved.

  本发明涉及对电压门控钠通道（如 TTX-S 通道）具有阻断活性的双芳基氧基衍生物，这些衍生物可用于治疗或预防涉及电压门控钠通道的紊乱和疾病。本发明还涉及包含这些化合物的药物组合物，以及这些化合物和组合物在预防或治疗涉及电压门控钠通道的此类疾病中的用途。
• BIARYLOXY DERIVATIVES AS TTX-S BLOCKERS
  申请人：RaQualia Pharma Inc.

  公开号：EP3676248A1

  公开（公告）日：2020-07-08